BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 37246627)

  • 21. Hepatitis B virus-associated B-cell non-Hodgkin lymphoma in non-endemic areas in Western Europe: Clinical characteristics and prognosis.
    Lemaitre M; Brice P; Frigeni M; Hermine O; Arcaini L; Thieblemont C; Besson C
    J Infect; 2020 Feb; 80(2):219-224. PubMed ID: 31846632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of adolescents with aggressive B-cell malignancies: the pediatric experience.
    Lange J; Burkhardt B
    Curr Hematol Malig Rep; 2013 Sep; 8(3):226-35. PubMed ID: 23812872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high-grade B-cell lymphoma.
    Graef CM; Gödel P; Falderbaum P; Balke-Want H; Simon F; Sieg N; Naendrup JH; Neumann MA; Gillessen S; Bröckelmann PJ; Eichenauer DA; Borchmann P; von Tresckow B; Heger JM
    Eur J Haematol; 2022 May; 108(5):403-412. PubMed ID: 35090068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol.
    Pillon M; Mussolin L; Carraro E; Conter V; Aricò M; Vinti L; Garaventa A; Piglione M; Buffardi S; Sala A; Santoro N; Lo Nigro L; Mura R; Tondo A; Casale F; Farruggia P; Pierani P; Cesaro S; d'Amore ES; Basso G
    Br J Haematol; 2016 Nov; 175(3):467-475. PubMed ID: 27392319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNAs expression levels in diffuse large B-cell lymphoma: An in silico analysis.
    Dousti F; Shahrisa A; Ansari H; Hajjari M; Tahmasebi Birgani Y; Mohammadiasl J; Tahmasebi Birgani M
    Pathol Res Pract; 2018 Sep; 214(9):1462-1466. PubMed ID: 30104077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma.
    Maes A; Maes K; De Raeve H; De Smedt E; Vlummens P; Szablewski V; Devin J; Faict S; De Veirman K; Menu E; Offner F; Spaargaren M; Moreaux J; Vanderkerken K; Van Valckenborgh E; De Bruyne E
    Br J Cancer; 2019 Jun; 120(12):1137-1146. PubMed ID: 31089208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma.
    Witzig TE; Nowakowski GS; Habermann TM; Goy A; Hernandez-Ilizaliturri FJ; Chiappella A; Vitolo U; Fowler N; Czuczman MS
    Ann Oncol; 2015 Aug; 26(8):1667-77. PubMed ID: 25712458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma.
    Maes A; Maes K; Vlummens P; De Raeve H; Devin J; Szablewski V; De Veirman K; Menu E; Moreaux J; Vanderkerken K; De Bruyne E
    Blood Cancer J; 2019 Nov; 9(12):87. PubMed ID: 31740676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
    Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
    Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas.
    Pham LV; Huang S; Zhang H; Zhang J; Bell T; Zhou S; Pogue E; Ding Z; Lam L; Westin J; Davis RE; Young KH; Medeiros LJ; Ford RJ; Nomie K; Zhang L; Wang M
    Clin Cancer Res; 2018 Aug; 24(16):3967-3980. PubMed ID: 29666304
    [No Abstract]   [Full Text] [Related]  

  • 31. BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines.
    Diepstraten ST; Chang C; Tai L; Gong JN; Lan P; Dowell AC; Taylor GS; Strasser A; Kelly GL
    Blood Adv; 2020 Jan; 4(2):356-366. PubMed ID: 31985804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [B-cell lymphoma, unclassifiable, intermediate between diffuse large B-cell lymphoma and Burkitt's lymphoma].
    Baryakh EA; Misyurina AE; Kovrigina AM; Misyurin VA; Kravchenko SK
    Ter Arkh; 2015; 87(4):91-97. PubMed ID: 26087641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research on Ralation of Long Non-coding RNA with Diffuse Large B-cell Lymphomas -Review].
    Wu YY; Xing YR; Yu DN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):609-614. PubMed ID: 29665941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 7-[[(4-methyl-2-pyridinyl)amino](2-pyridinyl)methyl]-8-quinolinol (compound 30666) inhibits enhancer activity and reduces B-cell lymphoma growth - A question of specificity.
    Kasprzyk ME; Łosiewski W; Podralska M; Kazimierska M; Sura W; Dzikiewicz-Krawczyk A
    Eur J Pharmacol; 2021 Nov; 910():174505. PubMed ID: 34534532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AMG176, an MCL-1 inhibitor, is active in pre-clinical models of aggressive B-cell lymphomas.
    Torka P; Russell T; Mavis C; Gu J; Ghione P; Barth M; Hernandez-Ilizaliturri FJ
    Leuk Lymphoma; 2023 Jun; 64(6):1175-1185. PubMed ID: 37074033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort.
    Fernandes M; Marques H; Teixeira AL; Medeiros R
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis.
    Zhu Q; Li Y; Guo Y; Hu L; Xiao Z; Liu X; Wang J; Xu Q; Tong X
    J Cell Mol Med; 2019 Nov; 23(11):7395-7405. PubMed ID: 31483572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV associated Burkitt's lymphoma.
    Basavaraj A; Shinde A; Kulkarni R; Kadam DB; Chugh A
    J Assoc Physicians India; 2014 Aug; 62(8):723-7. PubMed ID: 25856946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase 2 Study of Daratumumab in Relapsed/Refractory Mantle-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma.
    Salles G; Gopal AK; Minnema MC; Wakamiya K; Feng H; Schecter JM; Wang M
    Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):275-284. PubMed ID: 30795996
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.